Diasorin

➤ 1 in 200 newborns is diagnosed with congenital CMV every year. ➤ 21 days is the window of time after birth that a newborn should be tested for congenital CMV. ➤ 60 minutes is how quickly Simplexa® Congenital CMV Direct can provide diagnostic results for saliva swab and/or urine samples. When a newborn may have congenital CMV, timely and accurate detection can make all the difference. To provide the best quality diagnostics for your newborn patients, implement the Simplexa® Congenital CMV Direct assay: the only FDA-cleared PCR assay for the detection of CMV in saliva swabs and urine in neonates. Attending #AAP2026 (American Academy of Pediatrics)? Stop by Booth #2731 to learn more about the Simplexa® Congenital CMV Direct assay: https://lnkd.in/eXdT2Y-Q #CongenitalCMV #NeonatalCare #Pediatrics #MolecularDiagnostics

Stop by Booth #2731 to explore the LIAISON NES®, connect with our team, and learn more about our work in diagnostic solutions. We look forward to engaging with healthcare professionals and industry peers throughout the event. Register today: https://hubs.li/Q04y6QtB0 #AAP2026 #LIAISONNES

Hepatitis delta is one of the most serious forms of viral hepatitis, yet awareness and diagnosis remain significant challenges. In the ADLM podcast "Hepatitis Delta: Dialogues on the Journey”, experts discuss the evolving hepatitis delta landscape, the journey of people living with hepatitis Delta, and the critical role diagnostics play in supporting earlier identification and disease management. Watch the conversation to hear perspectives on the challenges, opportunities, and innovations shaping care for patients affected by hepatitis delta. Watch now: https://lnkd.in/g38eZEuP #ADLM2026 #HepatitisDelta #Diagnostics #LiverDisease #InfectiousDisease #LaboratoryMedicine #HealthcareInnovation #Diasorin

We look forward to connecting with attendees at #AAP2026 in San Diego, October 2-6. Visit us at Booth #2731 to learn more about the LIAISON NES® and meet members of our team. We welcome the opportunity to discuss how diagnostic innovation helps support advances in healthcare and laboratory testing. Register for AAP 2026 (American Academy of Pediatrics): https://hubs.li/Q04y6HKj0 #AAP2026 #LIAISONNES

Happening Today! Register now: https://lnkd.in/ggTCn68K September 21 at 9:00 AM PT | 12:00 PM ET | 6:00 PM CET Diagnostic uncertainty can impact admissions, LOS, antimicrobial use, and costs. Join our live webinar to hear how healthcare organizations are using LIAISON® MeMed BV® to support more informed infection management decisions. Learn about the real-world impact of host-response diagnostics on: • Clinical decision-making • Antimicrobial stewardship • ED throughput and patient disposition • Hospital utilization and cost of care #Diasorin #MeMedBV #HostResponseDiagnostics #ClinicalDiagnostics #AntimicrobialStewardship

During Sepsis Awareness Month, healthcare organizations are reminded of the importance of rapid recognition and treatment of patients presenting with suspected infection. For emergency physicians, some of the most important decisions occur long before a diagnosis of sepsis is confirmed. One of the earliest and most consequential questions is: Is the infection bacterial or viral? The answer can influence antibiotic prescribing, patient management, and downstream resource utilization. Start with MeMed BV: https://lnkd.in/gEpWDTDZ MeMed BV is designed to help clinicians differentiate bacterial from viral infections by measuring the patient's host immune response. With results available in 35 minutes or less, MeMed BV provides clinically actionable information during the initial Emergency Department evaluation when treatment decisions are often being made. By helping address the question of whether an infection is more likely bacterial or viral, MeMed BV can provide valuable insight early in the patient's care journey and support antimicrobial stewardship efforts. Follow with BRAHMS PCT. While MeMed BV helps answer "bacterial or viral?", BRAHMS Procalcitonin (PCT) serves a complementary role. PCT is particularly valuable when obtained as part of the initial ED infection workup and then monitored serially over time. Trending PCT levels every 6 to 24 hours can provide additional insight into bacterial infection burden, disease progression, response to therapy, and antibiotic management decisions. For many clinicians, the greatest utility of PCT comes not from a single result alone, but from understanding how levels change over time. Two Biomarkers. Different Questions. MeMed BV  • Helps differentiate bacterial versus viral infections  • Supports early clinical decision making  • Results in 35 minutes or less  • Can support antimicrobial stewardship initiatives BRAHMS PCT  • Added to the initial infection or sepsis laboratory workup  • Supports assessment of bacterial infection burden  • Valuable when monitored serially every 6 to 24 hours  • May help inform antibiotic stewardship decisions and treatment response monitoring A More Complete Infection Assessment  Patients with suspected infection require rapid decisions, but no single diagnostic tool answers every question. MeMed BV and BRAHMS PCT provide complementary information across the patient journey: MeMed BV: Is the infection more likely bacterial or viral?  BRAHMS PCT: How is the bacterial infection responding over time? This Sepsis Awareness Month, consider how earlier clarity and longitudinal monitoring may help support more informed infection management decisions in the Emergency Department.

Sepsis is most often a challenging diagnosis. If the patient has systemic infection, antibiotic treatment needs to be started without any delay. But diagnosing infection in these patients is far from easy. "Infection Uncovered" is a new podcast series where international experts discuss the clinical questions physicians face every day–from diagnosis and stewardship to implementation and improving patient outcomes. Explore "Infection Uncovered," a new series featuring: • Dr. Ron Daniels, Consultant in Critical Care • Dr. Luke More, Consultant in Infectious Diseases • Ceri Phillips, Consultant Pharmacist - Antimicrobials 🎙️Listen now: INFECTION UNCOVERED PCT PODCAST SERIES 🎧 https://lnkd.in/gzkaYJh3

Early planning can make a significant difference when responding to Candida auris. In this upcoming Labroots webinar, Dr. Preeti Pancholi will discuss the growing impact of C. auris, the importance of timely laboratory identification, and strategies that can help strengthen surveillance and infection prevention efforts. Don't miss key insights that could help improve your healthcare facility’s preparedness for C. auris. Reserve your spot today: https://hubs.li/Q04xjX3b0 #CandidaAuris #InfectionPrevention #ClinicalMicrobiology #OutbreakPreparedness #MolecularDiagnostics

Today, on World Sepsis Day, we stand with the global healthcare community to raise awareness of sepsis and its impact on patients, families and healthcare systems worldwide. Greater awareness supports earlier recognition. Stronger collaboration helps drive more timely action. Continued investment in knowledge, education and innovation can improve how sepsis is recognized and managed. Progress starts by turning awareness into action. Together, we can make sepsis a global priority. #WorldSepsisDay #StopSepsisSaveLives #SepsisAwareness #Diasorin

As recent Cyclospora outbreaks have demonstrated, identifying the true cause of diarrheal illness can be challenging when symptoms overlap across multiple infectious agents. The LIAISON PLEX® GI Flex Assay helps laboratories quickly rule in or rule out a broad range of pathogens, supporting timely patient management and infection control decisions. Key benefits include: • Detection of bacterial, viral, and parasitic targets in a single assay • Inclusion of Cyclospora cayetanensis detection • Detection of 8 parasites among 24 total targets Flexible menu. Comprehensive answers. Intentional diagnostics. Learn more: https://hubs.li/Q04xcvG70 #GITesting #ClinicalDiagnostics #Cyclospora